ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,482,567, issued on Nov. 25, was assigned to Cerner Innovation Inc. (Kansas City, Mo.).
"Predicting newly incident chronic kidney disease" was invented by Douglas S. McNair (Leawood, Kan.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Systems, methods and computer-readable media are provided for identifying patients having an elevated near-term risk of chronic kidney disease (CKD) progression, including predicting an individual's risk of progression to Stage 3 CKD within a future time interval, which may be up to 36 months. Based on the prediction, appropriate care providers may be notified so that the risk of CKD progression may be mitigated. In an embo...